Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2013

Open Access 01-10-2013 | Research article

Bacterial lipopolysaccharides form procollagen-endotoxin complexes that trigger cartilage inflammation and degeneration: implications for the development of rheumatoid arthritis

Authors: Wolfgang Lorenz, Constanze Buhrmann, Ali Mobasheri, Cora Lueders, Mehdi Shakibaei

Published in: Arthritis Research & Therapy | Issue 5/2013

Login to get access

Abstract

Introduction

We have previously reported that bacterial toxins, especially endotoxins such as lipopolysaccharides (LPS), might be important causative agents in the pathogenesis of rheumatoid arthritis (RA) in an in vitro model that simulates the potential effects of residing in damp buildings. Since numerous inflammatory processes are linked with the nuclear factor-κB (NF-κB), we investigated in detail the effects of LPS on the NF-κB pathway and the postulated formation of procollagen-endotoxin complexes.

Methods

An in vitro model of human chondrocytes was used to investigate LPS-mediated inflammatory signaling.

Results

Immunoelectron microscopy revealed that LPS physically interact with collagen type II in the extracellular matrix (ECM) and anti-collagen type II significantly reduced this interaction. BMS-345541 (a specific inhibitor of IκB kinase (IKK)) or wortmannin (a specific inhibitor of phosphatidylinositol 3-kinase (PI-3K)) inhibited the LPS-induced degradation of the ECM and apoptosis in chondrocytes. This effect was completely inhibited by combining BMS-345541 and wortmannin. Furthermore, BMS-345541 and/or wortmannin suppressed the LPS-induced upregulation of catabolic enzymes that mediate ECM degradation (matrix metalloproteinases-9, -13), cyclooxygenase-2 and apoptosis (activated caspase-3). These proteins are regulated by NF-κB, suggesting that the NF-κB and PI-3K pathways are involved in LPS-induced cartilage degradation. The induction of NF-κB correlated with activation of IκBα kinase, IκBα phosphorylation, IκBα degradation, p65 phosphorylation and p65 nuclear translocation. Further upstream, LPS induced the expression of Toll-like receptor 4 (TLR4) and bound with TLR4, indicating that LPS acts through TLR4.

Conclusion

These results suggest that molecular associations between LPS/TLR4/collagen type II in chondrocytes upregulate the NF-κB and PI-3K signaling pathways and activate proinflammatory activity.
Appendix
Available only for authorised users
Literature
2.
go back to reference Feldmann M, Brennan FM, Williams RO, Elliott MJ, Maini RN: Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action. J Inflamm. 1995, 47: 90-96.PubMed Feldmann M, Brennan FM, Williams RO, Elliott MJ, Maini RN: Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action. J Inflamm. 1995, 47: 90-96.PubMed
3.
4.
go back to reference Smolen JS, Steiner G: Rheumatoid arthritis is more than cytokines: autoimmunity and rheumatoid arthritis. Arthritis Rheum. 2001, 44: 2218-2220.CrossRefPubMed Smolen JS, Steiner G: Rheumatoid arthritis is more than cytokines: autoimmunity and rheumatoid arthritis. Arthritis Rheum. 2001, 44: 2218-2220.CrossRefPubMed
5.
go back to reference Ospelt C, Gay S: The role of resident synovial cells in destructive arthritis. Best Pract Res Clin Rheumatol. 2008, 22: 239-252.CrossRefPubMed Ospelt C, Gay S: The role of resident synovial cells in destructive arthritis. Best Pract Res Clin Rheumatol. 2008, 22: 239-252.CrossRefPubMed
6.
go back to reference Brand DD, Kang AH, Rosloniec EF: Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol. 2003, 25: 3-18.CrossRefPubMed Brand DD, Kang AH, Rosloniec EF: Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol. 2003, 25: 3-18.CrossRefPubMed
7.
go back to reference Trenkmann M, Brock M, Ospelt C, Gay S: Epigenetics in rheumatoid arthritis. Clin Rev Allergy Immunol. 2010, 39: 10-19.CrossRefPubMed Trenkmann M, Brock M, Ospelt C, Gay S: Epigenetics in rheumatoid arthritis. Clin Rev Allergy Immunol. 2010, 39: 10-19.CrossRefPubMed
8.
go back to reference Fox DA: The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum. 1997, 40: 598-609.CrossRefPubMed Fox DA: The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum. 1997, 40: 598-609.CrossRefPubMed
10.
go back to reference Okamoto H, Hoshi D, Kiire A, Yamanaka H, Kamatani N: Molecular targets of rheumatoid arthritis. Inflamm Allergy Drug Targets. 2008, 7: 53-66.CrossRefPubMed Okamoto H, Hoshi D, Kiire A, Yamanaka H, Kamatani N: Molecular targets of rheumatoid arthritis. Inflamm Allergy Drug Targets. 2008, 7: 53-66.CrossRefPubMed
11.
go back to reference Feldmann M, Maini RN: Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?. Annu Rev Immunol. 2001, 19: 163-196.CrossRefPubMed Feldmann M, Maini RN: Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?. Annu Rev Immunol. 2001, 19: 163-196.CrossRefPubMed
12.
go back to reference Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999, 402: 304-309.CrossRefPubMed Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999, 402: 304-309.CrossRefPubMed
13.
go back to reference Gutierrez-Ramos JC, Bluethmann H: Molecules and mechanisms operating in septic shock: lessons from knockout mice. Immunol Today. 1997, 18: 329-334.CrossRefPubMed Gutierrez-Ramos JC, Bluethmann H: Molecules and mechanisms operating in septic shock: lessons from knockout mice. Immunol Today. 1997, 18: 329-334.CrossRefPubMed
14.
go back to reference Sehic E, Li S, Ungar AL, Blatteis CM: Complement reduction impairs the febrile response of guinea pigs to endotoxin. Am J Physiol. 1998, 274: R1594-1603.PubMed Sehic E, Li S, Ungar AL, Blatteis CM: Complement reduction impairs the febrile response of guinea pigs to endotoxin. Am J Physiol. 1998, 274: R1594-1603.PubMed
15.
go back to reference Ross TN, Kisiday JD, Hess T, McIlwraith CW: Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide. Osteoarthritis Cartilage. 2012, 20: 1583-1590.CrossRefPubMed Ross TN, Kisiday JD, Hess T, McIlwraith CW: Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide. Osteoarthritis Cartilage. 2012, 20: 1583-1590.CrossRefPubMed
16.
go back to reference Ni M, MacFarlane AW, Toft M, Lowell CA, Campbell KS, Hamerman JA: B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K. Proc Natl Acad Sci USA. 2012, 109: 267-272.PubMedCentralCrossRefPubMed Ni M, MacFarlane AW, Toft M, Lowell CA, Campbell KS, Hamerman JA: B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K. Proc Natl Acad Sci USA. 2012, 109: 267-272.PubMedCentralCrossRefPubMed
17.
go back to reference Ulevitch RJ, Tobias PS: Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol. 1995, 13: 437-457.CrossRefPubMed Ulevitch RJ, Tobias PS: Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol. 1995, 13: 437-457.CrossRefPubMed
18.
go back to reference Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M: MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med. 1999, 189: 1777-1782.PubMedCentralCrossRefPubMed Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M: MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med. 1999, 189: 1777-1782.PubMedCentralCrossRefPubMed
19.
go back to reference Lorenz W, Sigrist G, Shakibaei M, Mobasheri A, Trautmann C: A hypothesis for the origin and pathogenesis of rheumatoid diseases. Rheumatol Int. 2006, 26: 641-654.CrossRefPubMed Lorenz W, Sigrist G, Shakibaei M, Mobasheri A, Trautmann C: A hypothesis for the origin and pathogenesis of rheumatoid diseases. Rheumatol Int. 2006, 26: 641-654.CrossRefPubMed
20.
go back to reference Purokivi MK, Hirvonen MR, Randell JT, Roponen MH, Meklin TM, Nevalainen AL, Husman TM, Tukiainen HO: Changes in pro-inflammatory cytokines in association with exposure to moisture-damaged building microbes. Eur Respir J. 2001, 18: 951-958.CrossRefPubMed Purokivi MK, Hirvonen MR, Randell JT, Roponen MH, Meklin TM, Nevalainen AL, Husman TM, Tukiainen HO: Changes in pro-inflammatory cytokines in association with exposure to moisture-damaged building microbes. Eur Respir J. 2001, 18: 951-958.CrossRefPubMed
21.
go back to reference Seuri M, Husman K, Kinnunen H, Reiman M, Kreus R, Kuronen P, Lehtomaki K, Paananen M: An outbreak of respiratory diseases among workers at a water-damaged building--a case report. Indoor Air. 2000, 10: 138-145.CrossRefPubMed Seuri M, Husman K, Kinnunen H, Reiman M, Kreus R, Kuronen P, Lehtomaki K, Paananen M: An outbreak of respiratory diseases among workers at a water-damaged building--a case report. Indoor Air. 2000, 10: 138-145.CrossRefPubMed
22.
go back to reference Sethi G, Ahn KS, Aggarwal BB: Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res. 2008, 6: 1059-1070.CrossRefPubMed Sethi G, Ahn KS, Aggarwal BB: Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res. 2008, 6: 1059-1070.CrossRefPubMed
23.
go back to reference Tas SW, Remans PH, Reedquist KA, Tak PP: Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therapy. Curr Pharm Des. 2005, 11: 581-611.CrossRefPubMed Tas SW, Remans PH, Reedquist KA, Tak PP: Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therapy. Curr Pharm Des. 2005, 11: 581-611.CrossRefPubMed
24.
go back to reference Reddy SA, Huang JH, Liao WS: Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. J Biol Chem. 1997, 272: 29167-29173.CrossRefPubMed Reddy SA, Huang JH, Liao WS: Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation. J Biol Chem. 1997, 272: 29167-29173.CrossRefPubMed
25.
go back to reference Reddy SA, Huang JH, Liao WS: Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation. J Immunol. 2000, 164: 1355-1363.CrossRefPubMed Reddy SA, Huang JH, Liao WS: Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation. J Immunol. 2000, 164: 1355-1363.CrossRefPubMed
26.
go back to reference Burgering BM, Coffer PJ: Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 1995, 376: 599-602.CrossRefPubMed Burgering BM, Coffer PJ: Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 1995, 376: 599-602.CrossRefPubMed
27.
go back to reference Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, Mapp PI, Morris CJ, Blake DR, Kaltschmidt C, Baeuerle PA: Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum. 1996, 39: 583-591.CrossRefPubMed Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, Mapp PI, Morris CJ, Blake DR, Kaltschmidt C, Baeuerle PA: Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum. 1996, 39: 583-591.CrossRefPubMed
28.
go back to reference Schett G, Stach C, Zwerina J, Voll R, Manger B: How antirheumatic drugs protect joints from damage in rheumatoid arthritis. Arthritis Rheum. 2008, 58: 2936-2948.CrossRefPubMed Schett G, Stach C, Zwerina J, Voll R, Manger B: How antirheumatic drugs protect joints from damage in rheumatoid arthritis. Arthritis Rheum. 2008, 58: 2936-2948.CrossRefPubMed
29.
go back to reference Barnes PJ, Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997, 336: 1066-1071.CrossRefPubMed Barnes PJ, Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997, 336: 1066-1071.CrossRefPubMed
30.
go back to reference Kumar A, Takada Y, Boriek AM, Aggarwal BB: Nuclear factor-kappaB: its role in health and disease. J Mol Med (Berl). 2004, 82: 434-448.CrossRef Kumar A, Takada Y, Boriek AM, Aggarwal BB: Nuclear factor-kappaB: its role in health and disease. J Mol Med (Berl). 2004, 82: 434-448.CrossRef
31.
go back to reference Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, Mobasheri A: Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol. 2007, 73: 1434-1445.CrossRefPubMed Shakibaei M, John T, Schulze-Tanzil G, Lehmann I, Mobasheri A: Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol. 2007, 73: 1434-1445.CrossRefPubMed
32.
go back to reference Shakibaei M: Inhibition of chondrogenesis by integrin antibody in vitro. Exp Cell Res. 1998, 240: 95-106.CrossRefPubMed Shakibaei M: Inhibition of chondrogenesis by integrin antibody in vitro. Exp Cell Res. 1998, 240: 95-106.CrossRefPubMed
33.
go back to reference Busch F, Mobasheri A, Shayan P, Lueders C, Stahlmann R, Shakibaei M: Resveratrol modulates interleukin-1beta-induced phosphatidylinositol 3-kinase and nuclear factor kappaB signaling pathways in human tenocytes. J Biol Chem. 2012, 287: 38050-38063.PubMedCentralCrossRefPubMed Busch F, Mobasheri A, Shayan P, Lueders C, Stahlmann R, Shakibaei M: Resveratrol modulates interleukin-1beta-induced phosphatidylinositol 3-kinase and nuclear factor kappaB signaling pathways in human tenocytes. J Biol Chem. 2012, 287: 38050-38063.PubMedCentralCrossRefPubMed
34.
go back to reference Shakibaei M, John T, De Souza P, Rahmanzadeh R, Merker HJ: Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor. Biochem J. 1999, 342: 615-623.PubMedCentralCrossRefPubMed Shakibaei M, John T, De Souza P, Rahmanzadeh R, Merker HJ: Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor. Biochem J. 1999, 342: 615-623.PubMedCentralCrossRefPubMed
35.
go back to reference Shakibaei M, Schulze-Tanzil G, de Souza P, John T, Rahmanzadeh M, Rahmanzadeh R, Merker HJ: Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes. J Biol Chem. 2001, 276: 13289-13294.CrossRefPubMed Shakibaei M, Schulze-Tanzil G, de Souza P, John T, Rahmanzadeh M, Rahmanzadeh R, Merker HJ: Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes. J Biol Chem. 2001, 276: 13289-13294.CrossRefPubMed
36.
go back to reference Shakibaei M, Zimmermann B, Merker HJ: Changes in integrin expression during chondrogenesis in vitro: an immunomorphological study. J Histochem Cytochem. 1995, 43: 1061-1069.CrossRefPubMed Shakibaei M, Zimmermann B, Merker HJ: Changes in integrin expression during chondrogenesis in vitro: an immunomorphological study. J Histochem Cytochem. 1995, 43: 1061-1069.CrossRefPubMed
37.
go back to reference Shakibaei M, Csaki C, Nebrich S, Mobasheri A: Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol. 2008, 76: 1426-1439.CrossRefPubMed Shakibaei M, Csaki C, Nebrich S, Mobasheri A: Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol. 2008, 76: 1426-1439.CrossRefPubMed
38.
go back to reference Shakibaei M, Abou-Rebyeh H, Merker HJ: Integrins in ageing cartilage tissue in vitro. Histol Histopathol. 1993, 8: 715-723.PubMed Shakibaei M, Abou-Rebyeh H, Merker HJ: Integrins in ageing cartilage tissue in vitro. Histol Histopathol. 1993, 8: 715-723.PubMed
39.
go back to reference Romano M, Claria J: Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J. 2003, 17: 1986-1995.CrossRefPubMed Romano M, Claria J: Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J. 2003, 17: 1986-1995.CrossRefPubMed
40.
go back to reference Goldring MB: The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res. 1999, 40: 1-11.CrossRefPubMed Goldring MB: The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res. 1999, 40: 1-11.CrossRefPubMed
41.
go back to reference Burke JR, Pattoli MA, Gregor KR, Brassil PJ, MacMaster JF, McIntyre KW, Yang X, Iotzova VS, Clarke W, Strnad J, Qiu Y, Zusi FC: BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem. 2003, 278: 1450-1456.CrossRefPubMed Burke JR, Pattoli MA, Gregor KR, Brassil PJ, MacMaster JF, McIntyre KW, Yang X, Iotzova VS, Clarke W, Strnad J, Qiu Y, Zusi FC: BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem. 2003, 278: 1450-1456.CrossRefPubMed
42.
go back to reference Ghosh S, Karin M: Missing pieces in the NF-kappaB puzzle. Cell. 2002, S81-96. 109 Suppl Ghosh S, Karin M: Missing pieces in the NF-kappaB puzzle. Cell. 2002, S81-96. 109 Suppl
43.
go back to reference Metcalfe D, Harte AL, Aletrari MO, Al Daghri NM, Al Disi D, Tripathi G, McTernan PG: Does endotoxaemia contribute to osteoarthritis in obese patients?. Clin Sci (Lond). 2012, 123: 627-634.CrossRef Metcalfe D, Harte AL, Aletrari MO, Al Daghri NM, Al Disi D, Tripathi G, McTernan PG: Does endotoxaemia contribute to osteoarthritis in obese patients?. Clin Sci (Lond). 2012, 123: 627-634.CrossRef
44.
go back to reference Myllyharju J, Kivirikko KI: Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet. 2004, 20: 33-43.CrossRefPubMed Myllyharju J, Kivirikko KI: Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet. 2004, 20: 33-43.CrossRefPubMed
45.
go back to reference Peiser L, Mukhopadhyay S, Gordon S: Scavenger receptors in innate immunity. Curr Opin Immunol. 2002, 14: 123-128.CrossRefPubMed Peiser L, Mukhopadhyay S, Gordon S: Scavenger receptors in innate immunity. Curr Opin Immunol. 2002, 14: 123-128.CrossRefPubMed
46.
go back to reference Hintz KA, Rassias AJ, Wardwell K, Moss ML, Morganelli PM, Pioli PA, Givan AL, Wallace PK, Yeager MP, Guyre PM: Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. J Leukoc Biol. 2002, 72: 711-717.PubMed Hintz KA, Rassias AJ, Wardwell K, Moss ML, Morganelli PM, Pioli PA, Givan AL, Wallace PK, Yeager MP, Guyre PM: Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. J Leukoc Biol. 2002, 72: 711-717.PubMed
47.
go back to reference Campo GM, Avenoso A, Campo S, D'Ascola A, Nastasi G, Calatroni A: Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. Biochimie. 2010, 92: 204-215.CrossRefPubMed Campo GM, Avenoso A, Campo S, D'Ascola A, Nastasi G, Calatroni A: Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. Biochimie. 2010, 92: 204-215.CrossRefPubMed
48.
go back to reference Campo GM, Avenoso A, Campo S, D'Ascola A, Traina P, Rugolo CA, Calatroni A: Differential effect of molecular mass hyaluronan on lipopolysaccharide-induced damage in chondrocytes. Innate Immun. 2010, 16: 48-63.CrossRefPubMed Campo GM, Avenoso A, Campo S, D'Ascola A, Traina P, Rugolo CA, Calatroni A: Differential effect of molecular mass hyaluronan on lipopolysaccharide-induced damage in chondrocytes. Innate Immun. 2010, 16: 48-63.CrossRefPubMed
49.
go back to reference Campo GM, Avenoso A, Campo S, D'Ascola A, Traina P, Sama D, Calatroni A: Purified human plasma glycosaminoglycans reduced NF-kappaB activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes. Innate Immun. 2008, 14: 233-246.CrossRefPubMed Campo GM, Avenoso A, Campo S, D'Ascola A, Traina P, Sama D, Calatroni A: Purified human plasma glycosaminoglycans reduced NF-kappaB activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes. Innate Immun. 2008, 14: 233-246.CrossRefPubMed
50.
go back to reference Campo GM, Avenoso A, Campo S, D'Ascola A, Traina P, Sama D, Calatroni A: Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. J Cell Biochem. 2009, 106: 83-92.CrossRefPubMed Campo GM, Avenoso A, Campo S, D'Ascola A, Traina P, Sama D, Calatroni A: Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. J Cell Biochem. 2009, 106: 83-92.CrossRefPubMed
51.
go back to reference Campo GM, Avenoso A, Campo S, Traina P, D'Ascola A, Calatroni A: Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes. Arch Biochem Biophys. 2009, 491: 7-15.CrossRefPubMed Campo GM, Avenoso A, Campo S, Traina P, D'Ascola A, Calatroni A: Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes. Arch Biochem Biophys. 2009, 491: 7-15.CrossRefPubMed
52.
go back to reference Grall F, Gu X, Tan L, Cho JY, Inan MS, Pettit AR, Thamrongsak U, Choy BK, Manning C, Akbarali Y, Zerbini L, Rudders S, Goldring SR, Gravallese EM, Oettgen P, Goldring MB, Libermann TA: Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum. 2003, 48: 1249-1260.CrossRefPubMed Grall F, Gu X, Tan L, Cho JY, Inan MS, Pettit AR, Thamrongsak U, Choy BK, Manning C, Akbarali Y, Zerbini L, Rudders S, Goldring SR, Gravallese EM, Oettgen P, Goldring MB, Libermann TA: Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum. 2003, 48: 1249-1260.CrossRefPubMed
53.
go back to reference Kim HA, Cho ML, Choi HY, Yoon CS, Jhun JY, Oh HJ, Kim HY: The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum. 2006, 54: 2152-2163.CrossRefPubMed Kim HA, Cho ML, Choi HY, Yoon CS, Jhun JY, Oh HJ, Kim HY: The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum. 2006, 54: 2152-2163.CrossRefPubMed
54.
go back to reference Madhavan S, Anghelina M, Sjostrom D, Dossumbekova A, Guttridge DC, Agarwal S: Biomechanical signals suppress TAK1 activation to inhibit NF-kappaB transcriptional activation in fibrochondrocytes. J Immunol. 2007, 179: 6246-6254.CrossRefPubMed Madhavan S, Anghelina M, Sjostrom D, Dossumbekova A, Guttridge DC, Agarwal S: Biomechanical signals suppress TAK1 activation to inhibit NF-kappaB transcriptional activation in fibrochondrocytes. J Immunol. 2007, 179: 6246-6254.CrossRefPubMed
55.
go back to reference Kane LP, Shapiro VS, Stokoe D, Weiss A: Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol. 1999, 9: 601-604.CrossRefPubMed Kane LP, Shapiro VS, Stokoe D, Weiss A: Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol. 1999, 9: 601-604.CrossRefPubMed
56.
go back to reference Romashkova JA, Makarov SS: NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999, 401: 86-90.CrossRefPubMed Romashkova JA, Makarov SS: NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999, 401: 86-90.CrossRefPubMed
57.
go back to reference Gustin JA, Maehama T, Dixon JE, Donner DB: The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity. J Biol Chem. 2001, 276: 27740-27744.CrossRefPubMed Gustin JA, Maehama T, Dixon JE, Donner DB: The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity. J Biol Chem. 2001, 276: 27740-27744.CrossRefPubMed
58.
go back to reference Buhrmann C, Mobasheri A, Busch F, Aldinger C, Stahlmann R, Montaseri A, Shakibaei M: Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem. 2011, 286: 28556-28566.PubMedCentralCrossRefPubMed Buhrmann C, Mobasheri A, Busch F, Aldinger C, Stahlmann R, Montaseri A, Shakibaei M: Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem. 2011, 286: 28556-28566.PubMedCentralCrossRefPubMed
59.
go back to reference Csaki C, Mobasheri A, Shakibaei M: Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther. 2009, 11: R165-PubMedCentralCrossRefPubMed Csaki C, Mobasheri A, Shakibaei M: Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther. 2009, 11: R165-PubMedCentralCrossRefPubMed
60.
go back to reference Zhang C, Li B, Zhang X, Hazarika P, Aggarwal BB, Duvic M: Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling. J Invest Dermatol. 2010, 130: 2110-2119.CrossRefPubMed Zhang C, Li B, Zhang X, Hazarika P, Aggarwal BB, Duvic M: Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling. J Invest Dermatol. 2010, 130: 2110-2119.CrossRefPubMed
61.
go back to reference Creely SJ, McTernan PG, Kusminski CM, Fisher f M, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S: Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab. 2007, 292: E740-747.CrossRefPubMed Creely SJ, McTernan PG, Kusminski CM, Fisher f M, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S: Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab. 2007, 292: E740-747.CrossRefPubMed
62.
go back to reference Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Scherer PE: The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem. 2000, 275: 24255-24263.CrossRefPubMed Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Scherer PE: The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem. 2000, 275: 24255-24263.CrossRefPubMed
Metadata
Title
Bacterial lipopolysaccharides form procollagen-endotoxin complexes that trigger cartilage inflammation and degeneration: implications for the development of rheumatoid arthritis
Authors
Wolfgang Lorenz
Constanze Buhrmann
Ali Mobasheri
Cora Lueders
Mehdi Shakibaei
Publication date
01-10-2013
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2013
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4291

Other articles of this Issue 5/2013

Arthritis Research & Therapy 5/2013 Go to the issue